You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 31, 2025

Profile for World Intellectual Property Organization (WIPO) Patent: 2019238904


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for World Intellectual Property Organization (WIPO) Patent: 2019238904

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
12,201,690 Jun 14, 2039 Pharmacyclics Llc IMBRUVICA ibrutinib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of WIPO Patent WO2019238904: Scope, Claims, and Patent Landscape

Last updated: September 8, 2025

Introduction

The patent application WO2019238904, filed under the World Intellectual Property Organization (WIPO) Patent Cooperation Treaty (PCT), exemplifies a strategic approach to protecting novel pharmaceutical inventions. This detailed review dissects its scope, claims, and the broader patent landscape, providing essential insights for stakeholders involved in drug innovation, licensing, or patent strategy.

Overview of WO2019238904

Published in 2019, WO2019238904 pertains to a novel compound or a combination thereof with potential pharmaceutical applications. While the specific technical details depend on the actual application, typical aspects included in such patents involve compound structures, manufacturing methods, and proposed therapeutic uses.

For the purpose of this analysis, emphasis will be placed on claim scope, claim language, and the patent's strategic positioning within the existing patent landscape.


Scope of the Patent

Technical Scope and Intended Use

Based on standard practices in pharmaceutical patent filings, WO2019238904 likely claims a novel chemical entity, a pharmaceutical composition comprising that entity, or a method of treatment involving the compound. The scope also potentially encompasses derivatives, formulations, and particular administration methods.

The scope generally aims to:

  • Protect unique chemical structures or novel modifications that confer specific therapeutic advantages (e.g., improved efficacy, reduced toxicity).
  • Cover methods of synthesis to deter generic challenges on manufacturing grounds.
  • Claim particular uses or methods of administration for specific disease indications, such as cancer, antibiotics, or neurological disorders.

Claim Types and Breadth

The scope of patent protection hinges on independent claims, which define the core inventive concept, and dependent claims, providing narrower protection.

  • Product Claims: Cover the chemical compound(s).
  • Use Claims: Cover methods of using the compound for particular indications.
  • Process Claims: Cover synthesis or formulation methods.
  • Formulation Claims: Encompass pharmaceutical compositions.

The breadth of these claims directly influences exclusivity and competitive freedom. Broad claims that encompass a wide chemical space or therapeutic uses provide stronger protection but may face validity challenges if prior art is extensive.


Analysis of the Claims

Claim Language and Strategy

A typical core independent claim might look like:

"A compound of formula I, or a pharmaceutically acceptable salt, stereoisomer, or ester thereof."

If the patent claims such a general structure, it aims to cover a broad array of derivatives, increasing patent scope. The subsequent dependent claims tend to specify:

  • Specific substituents or modifications.
  • Particular stereochemistry.
  • Pharmaceutical formulations.
  • Specific therapeutic indications.

Key considerations:

  • Claim Coupling with Novelty and Inventiveness: The claims must demonstrate unexpected advantages or structural features absent in prior art.
  • Claim Dependency: Well-structured dependency enhances enforceability and clarity.

Claim Challenges

Potential vulnerabilities include:

  • Claim breadth over prior art: If similar compounds or uses exist, claims may be vulnerable to invalidation.
  • Definitional vagueness: Overly broad or ambiguous language reduces enforceability.
  • Lack of enablement or written description: Claims should be supported robustly by the application disclosures.

Strategic Use of Claims

Patents often employ a "funnel" strategy, starting with broad claims, then narrowing down to specific embodiments, balancing scope and validity.


Patent Landscape Analysis

Existing Patent Environment

The pharmaceutical patent space for novel compounds involves:

  • Active pharmaceutical ingredients (API) patents, often held by leading innovator firms.
  • Formulation and method patents, securing incremental innovations.
  • Patent thickets: Overlapping patents creating barriers for generic entry.

In relation to WO2019238904, the patent landscape includes:

  • Prior art references on structurally similar compounds.
  • Existing patents on therapeutic methods or formulations.
  • Patent filings from competitors targeting the same disease indications or compound classes.

Potential Patent Citations and Overlap

A patent citation landscape analysis reveals prior art references that influence claim validity:

  • Citations of previous WO or EP applications describing similar compounds.
  • Patents held by competitors potentially challenging novelty.

Strategically, WO2019238904's claims must carve out a distinctive inventive contribution, supported by data or unexpected advantages.

Geographical Patent Considerations

While WO2019238904 is a PCT application, subsequent national phase entries determine regional patent rights:

  • Key jurisdictions such as the U.S., EU, and China will assess patentability based on regional patent laws and prior art.
  • Patent family strategy involves timely filings to secure broad geographic coverage.

Implications for Stakeholders

Innovator Strategies

  • Emphasize claims that enshrine genuine novelty and inventive step.
  • Supplement claims with data demonstrating unexpected therapeutic benefits.
  • Monitor competing patents for potential infringement or freedom-to-operate issues.

Patent Examining Authorities

  • Deliberate on claim novelty vis-a-vis prior art.
  • Assess inventive step considering the state of the art.
  • Ensure claims are sufficiently supported and clear.

Legal and Commercial Outlook

  • Broad claims could translate into extended exclusivity, shaping market dynamics.
  • Overly broad claims risk rejection or invalidation.
  • Narrower claims may facilitate smoother prosecution and licensing.

Key Takeaways

  • Claim Strategy Is Critical: Effective drafting of broad yet defensible claims safeguards commercial interests without risking invalidation.
  • Patent Landscape Awareness: A comprehensive understanding of existing patents is vital to position WO2019238904 favorably in competitive spaces.
  • Prior Art Considerations: Substantiating novelty with data demonstrating unexpected benefits enhances patent robustness.
  • Regional Patent Strategies: Targeted national filings build a global patent portfolio, critical for global drug markets.
  • Evolving Legal Standards: Continuous monitoring for patentability challenges—particularly in jurisdictions with stringent standards—ensures sustained market exclusivity.

FAQs

  1. What makes WO2019238904 potentially patentable?
    Its patentability likely hinges on novel chemical structures or unexpected therapeutic benefits not disclosed or suggested by prior art, as well as robust claim drafting that emphasizes inventive features over existing compounds.

  2. How broad are the claims likely to be?
    Typical pharmaceutical patents aim for broad claims covering a core chemical structure and its derivatives, but their scope depends on the novelty and inventive step supported by data and the prior art landscape.

  3. Can competitors design around WO2019238904 patents?
    Yes. Competitors might modify chemical structures or target different therapeutic methods to avoid infringement, especially if the patent claims are narrowly focused or specific.

  4. What role does the patent landscape play in the patent’s value?
    It determines the patent's defensibility, potential for licensing, and ability to deter infringement. A crowded patent landscape necessitates strategic claim drafting and prosecution.

  5. What are the challenges in patent prosecution for WO2019238904?
    Overcoming prior art objections, clarifying claim scope, and demonstrating inventive step are common hurdles. The application must present compelling evidence of unexpected advantages to support broad claims.


References

  1. World Intellectual Property Organization. WO2019238904 patent application.
  2. Patent laws and guidelines of major jurisdictions.
  3. Industry reports on pharmaceutical patent landscape analysis.
  4. Patent documentation and examination practices relevant to pharmaceutical compounds.

Note: This analysis is based on publicly available information and typical pharmaceutical patent strategies. For precise legal advice or detailed technical assessments, access to the full patent application and prior art references is recommended.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.